Aerovate Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -28 | -28 | ||
EBITDA | -6,395 | -17,192 | -26,137 | -24,590 |
EBIT | -6,403 | -17,410 | -26,165 | -24,618 |
Net Income | -5,430 | -16,237 | -24,775 | -23,186 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,047 | -16,043 | -20,433 | -23,673 |
Cash | 33,751 | 31,115 | 31,069 | 9,122 |
Basic Shares | 28,611 | 28,863 | 28,756 | 27,795 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -96 | -68 | -15 | |
EBITDA | -74,314 | -81,313 | -53,169 | -23,007 |
EBIT | -74,596 | -81,409 | -53,237 | -23,022 |
Net Income | -69,628 | -75,521 | -51,511 | -22,963 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -71,196 | -56,920 | -39,317 | -27,580 |
Cash | 33,751 | 23,491 | 22,397 | 54,197 |
Basic Shares | 28,582 | 26,331 | 24,472 | 24,410 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.19 |
2024-09-30 | -$0.56 |
2024-06-30 | -$0.86 |
2024-03-31 | -$0.83 |
